MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Long-term effects of a mobile technology-based brisk walking program on Parkinsonian symptoms in Parkinson’s disease – a randomized controlled trial

MKY. Mak, ISK. Wong-Yu (Hong Kong SAR, China)

Meeting: 2023 International Congress

Abstract Number: 91

Keywords: Gait disorders: Treatment, Parkinson’s, Rehabilitation

Category: Parkinson’s Disease: Clinical Trials

Objective: To evaluate the effectiveness of a 6-month mobile technology-based brisk walking program on motor and non-motor symptoms and self-perceived ability in people with Parkinson’s disease (PD).

Background: The 6-month brisk walking programme using smartwatch heart rate monitor alleviated non-motor symptoms at 6-week after training [1] and motor symptoms at post-training in people with PD [2]. As sustained aerobic training is beneficial in delaying PD symptom and disability progressions [3], it is important to explore the longer-term effects of this exercise program.

Method: People with mild to moderate PD were randomized into balance and brisk walking (EXP) or active control (CON) group with flexibility and upper limb strength training. Participants received 10 training sessions in 6 months supervised by physiotherapists and practised home exercise regularly. The use of smartwatch system enabled the participants to self-monitor heart rate response accurately [4] and complete 150-min weekly moderate-intensity exercise [5] throughout the course. Movement Disorder Society Unified Parkinson Rating Scale motor and self-perceived ability (MDS-UPDRS III and II) scores and Non-motor Rating Scale (MDS-NMS) scores were assessed before (Pre), after training (Post6m) and 6-month follow-up (FU6m).

Results: 128 PD volunteers (aged 62.4, PD duration 5.4 years and modified Hohen and Yahr stage 2.5) were randomized into the study. 117 participants (EXP=61; CON=56) completed the program with 96% in 6-month attendance rate. No adverse effects or falls was reported during training and self-practice. Significant group*time interactions were found in all outcome measures using 2-way repeated ANOVA in EXP group. At Post6m, there were significant decreases from baseline of MDS-UPDRS III and II scores (-4.0 and -2.2 points) and MDS-NMS score (-4.8 point) in EXP group (p<0.05). At FU6m, there were significant decreases of MDS-UPDRS III and II (-5.1 and -1.6 points) and MDS-NMS score (-1.7 point) in the same group (p<0.05).

Conclusion: The 6-month mobile technology-based brisk walking program alleviates parkinsonian symptoms and improved self-perceived ability up to 6-month follow-up in people with mild to moderate PD.

References: 1. Mak MK, Wong-Yu IS. Effects of combined balance and brisk walking on alleviating non-motor symptoms in Parkinson disease. The 12th Pan-Pacific Conference on Rehabilitation 2021 abstract.
2. Mak MK, Wong-Yu IS. Six-month community-based brisk walking and balance exercise alleviates motor symptoms and promotes functions in people with Parkinson’s disease: a randomized controlled trial. Journal of Parkinson’s Disease. 2021;11(3):1431-41.
3. Schootemeijer S, van der Kolk NM, Bloem BR, de Vries NM. Current perspectives on aerobic exercise in people with Parkinson’s disease. Neurotherapeutics. 2020;17:1418-33.
4. Mak MK, Ren L, Kong L, Wong-Yu IS. Validity of a physical activity tracker for heart rate measurement during aerobic exercise in people with Parkinson’s disease. Parkinsonism & Related Disorders. 2020;79:e42-3.
5. Benka Wallén M, Franzén E, Nero H, Hagströmer M. Levels and patterns of physical activity and sedentary behavior in elderly people with mild to moderate Parkinson disease. Physical therapy. 2015;95(8):1135-41.

To cite this abstract in AMA style:

MKY. Mak, ISK. Wong-Yu. Long-term effects of a mobile technology-based brisk walking program on Parkinsonian symptoms in Parkinson’s disease – a randomized controlled trial [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/long-term-effects-of-a-mobile-technology-based-brisk-walking-program-on-parkinsonian-symptoms-in-parkinsons-disease-a-randomized-controlled-trial/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/long-term-effects-of-a-mobile-technology-based-brisk-walking-program-on-parkinsonian-symptoms-in-parkinsons-disease-a-randomized-controlled-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley